enoxaparin


Also found in: Dictionary, Wikipedia.

enoxaparin

 [e-nok″sah-par´in]
a low molecular weight heparin, used as the sodium salt to prevent pulmonary embolism and deep venous thrombosis following hip or knee replacement or high-risk abdominal surgery; administered subcutaneously as the sodium salt. It is also used together with warfarin in the treatment of deep venous thrombosis and together with aspirin in the prevention of coronary thrombosis associated with unstable angina or certain kinds of myocardial infarction.

enoxaparin

(ē-noks'ă-par-in),
A low-molecular-weight heparin.

enoxaparin

/enox·a·par·in/ (e-nok″sah-par´in) a low molecular weight heparin used as the sodium salt as an antithrombotic.

enoxaparin

[e-nok′säpar′in]
a low-molecular-weight heparin used as the sodium salt to prevent pulmonary embolism and deep venous thrombosis after hip or knee replacement or high-risk abdominal surgery, administered subcutaneously as the sodium salt. It is also used together with warfarin in the treatment of deep venous thrombosis and together with aspirin in the prevention of coronary thrombosis associated with unstable angina or certain kinds of myocardial infarction.

enoxaparin

Lovenox® Vascular disease An LMW heparin anticoagulant used to prevent DVT, venous TE in Pts with acute medical disease, and to prevent ischemic complications of unstable angina and non-Q-wave MIs Adverse events Hemorrhage. See Deep vein thrombosis, Low-molecular-weight heparin.

enoxaparin

An anticoagulation drug used to prevent blood clots forming in the veins after surgery or to treat formed clots. It has been found superior to treatment with unfractionated heparin in patients on fibrinolysis for ST-elevation myocardial infarction but is associated with uncreased major bleeding episodes. A brand name is Clexane.
References in periodicals archive ?
Subcutaneous enoxaparin in a dose of 40 mg once daily did not improve the chance of live births in non-thrombophilic women with unexplained recurrent pregnancy loss when compared with the placebo.
Enoxaparin is the most widely studied LMWH, with most of the data stemming from its use in cardiovascular trials.
According to the subgroup analysis; live birth rates did not differ significantly between the enoxaparin and tinzaparin group (84% and 86% respectively).
5 mL; Arixtra, GlaxoSmithKline, Greenford, United Kingdom), enoxaparin (10 000 anti-Xa IU/mL; Clexane, Sanofi Aventis, Budapest, Hungary) and danaparoid solution (750 anti-Xa IU/0.
The favourable benefit-to-risk profile observed with semuloparin compared to enoxaparin in the classic major orthopedic surgery model supports the further evaluation of semuloparin as VTE preventative therapy in other areas including oncology, as VTE is a known complication in patients with cancer.
Before the transfer, bruising and slight swelling were observed on the patient's left side and chest, and a physician reportedly ordered that the enoxaparin be discontinued.
The study randomly assigned 8,101 patients hospitalized for an acute medical illness including heart failure, acute infectious disease, and acute respiratory insufficiency to oral rivaroxaban 10 mg daily for 35 days or subcutaneous enoxaparin 40 mg daily for 10 days plus placebo.
Prior to the approval, the agency received a citizen petition questioning the approval criteria for generic enoxaparin sodium injection.
The agency had previously received a citizen petition questioning the approval criteria for generic enoxaparin injection.
The dose-escalating, randomised, open-label phase II study evaluated TB-402 versus standard treatment enoxaparin for the prevention of VTE after knee surgery.
7% for patients on enoxaparin, for a relative risk reduction in total venous thromboembolism of 70%, Dr.
Enoxaparin is a low molecular weight heparin (LWMH) commonly used in clinics with few untoward effects pertaining to bleeding or hematoma.